Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. Post author:Sam Post published:December 18, 2017 Post category:BioPharma The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace You Might Also Like BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017 <b>IDF</b> And Novo Nordisk A/S Launch First-Ever Global Survey On Cardiovascular Disease Awareness Among People With Type 2 Diabetes September 28, 2017 Merck KGaA, Pfizer's Bavencio Flunks Late-Stage Gastric Cancer Trial November 27, 2017
BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017
<b>IDF</b> And Novo Nordisk A/S Launch First-Ever Global Survey On Cardiovascular Disease Awareness Among People With Type 2 Diabetes September 28, 2017
